Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Life Technologies Corp. (Life Technologies) said that a jury in the US District Court for the Northern District of California rendered a verdict in its favor in its patent-infringement dispute with Illumina Inc. In this dispute, Illumina, Inc. (Illumina) alleged that the SOLiD sequencing system commercialized by Applied Biosystems Inc. (Applied Biosystems), a subsidiary of Life Technologies, infringed three patents.
Subscribe to our email newsletter
After a seven day jury trial, the jury unanimously decided that the SOLiD sequencing technology did not infringe the patent.
“We are very pleased with the decisions by the Court and the jury in this action,” said Kip Miller, president, Genetic Systems Division at Life Technologies. “The SOLiD™ sequencing platform was developed through substantial R&D efforts within Applied Biosystems. These decisions validate our belief that the SOLiD™ sequencing system is unique in its design and paves the way for us to continue building on its innovative design and superlative performance with the upcoming launch of SOLiD 3.0 this February.”